StabiLux Biosciences Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 10
Employees
  • Latest Deal Type
  • Series A
  • (In Progress)
  • Latest Deal Amount
  • $3M
Latest Deal Amount
  • Investors
  • 7

StabiLux Biosciences General Information

Description

Developer of high-brightness fluorophores designed to improve the reagents that run through flow cytometers. The company's fluorophores are compatible with current flow cytometers and increase the brightness of fluorophores across the visible range with minimal or no noise distortion, enabling users to detect targeted or cancer cells feasibly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 22151 Ridge Road
  • Houghton, MI 49931
  • United States

StabiLux Biosciences Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

StabiLux Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 19-Mar-2021 $3M 00000 In Progress Generating Revenue
7. Accelerator/Incubator 01-Jan-2021 00000 Completed Generating Revenue
6. Later Stage VC 12-May-2020 00000 00000 Completed Generating Revenue
5. Later Stage VC 0000 Completed Generating Revenue
4. Grant 07-Nov-2017 00000 0000 Completed Generating Revenue
3. Early Stage VC 29-Sep-2017 0000 0000 Completed Generating Revenue
2. Grant 31-Dec-2016 $241K Completed Startup
1. Grant $319K Completed Startup
To view StabiLux Biosciences’s complete valuation and funding history, request access »

StabiLux Biosciences Executive Team (4)

Name Title Board Seat Contact Info
Yoke Yap Ph.D Co-Founder, Chief Technical Officer & President
Yoke Khin Yap Chief Technology Officer, President & Board Member
Nazmiye Yapici Lead Scientist & Board Observer
Steve Tokarz Chief Executive Officer & Board Member
To view StabiLux Biosciences’s complete executive team members history, request access »

StabiLux Biosciences Board Members (5)

Name Representing Role Since
Jon Leinonen StabiLux Biosciences Board Member 000 0000
Mark Ehlert StabiLux Biosciences Board Member 000 0000
Nazmiye Yapici StabiLux Biosciences Lead Scientist & Board Observer 000 0000
Steve Tokarz Self Chief Executive Officer & Board Member 000 0000
Yoke Khin Yap StabiLux Biosciences Chief Technology Officer, President & Board Member 000 0000
To view StabiLux Biosciences’s complete board members history, request access »

StabiLux Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StabiLux Biosciences Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Innovation Corps Program Accelerator/Incubator 000 0000 000000 0
Cantilever Investors Venture Capital Minority 000 0000 000000 0
Invest Detroit Ventures Corporate Venture Capital Minority 000 0000 000000 0
MGS Mfg. Group PE-Backed Company 000 0000 000000 0
Superior Innovations Corporation 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »